European Biotech Acquisition Corp. (EBAC) Stock Analysis

What European Biotech Acquisition Corp. does

European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.

Key metrics

ETFs linked to EBAC

Broad-market and Financial Services sector ETFs an investor holding European Biotech Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EBAC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for European Biotech Acquisition Corp.?

European Biotech Acquisition Corp. trades under the ticker EBAC on NASDAQ.

Which exchange is EBAC listed on?

EBAC is listed on NASDAQ.

What sector does European Biotech Acquisition Corp. operate in?

European Biotech Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze EBAC in a portfolio?

PortView shows EBAC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.